Risk factors for depression during perimenopause

Women's Reproductive Mental Health Across the Lifespan

Volumn , Issue , 2014, Pages 215-233

  Gibbs, Zoe ^a   Kulkarni, Jayashri ^a  

^a Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84930243517     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-05116-1_12     Document Type: Chapter

References (127)

1. Aksu H., Sevinçok L., Kücük M., Sezer S. D., & Oʇurlu N. (2011). The attitudes of menopausal women and their spouses towards menopause. Clinical & Experimental Obstetrics & Gynecology, 38 (3), 251-255
2. Arpels J. C. (1996). The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data. Journal of Reproductive Medicine, 41 (9), 633-639
3. Avis N. E., Brambilla D., McKinlay J. B., & Vass K. (1994). A longitudinal analysis of the association between menopause and depression: Results from the Massachusetts Women's Health Study. Annals of Epidemiology, 4 (3), 214-220
4. Avis N. E., Crawford S., & McKinlay S. M. (1997). Psychosocial, behavioural, and health factors related to menopause symptomatology. Women's Health, 3, 103-120
5. Avis N. E., & McKinlay S. M. (1991). A longitudinal analysis of women's attitudes toward the menopause: Results from the Massachusetts Women's Health Study. Maturitas, 13 (1), 65-79
6. Ballinger S. (1985). Psychosocial stress and symptoms of menopause: A comparative study of menopause clinic patients and non-patients. Maturitas, 7, 315-327
7. Barber C. E. (1989). Transition to the empty nest. In S. J. Bahr & E. T. Peterson (Eds.), Ageing and the family (pp. 15-32). Lexington, MA: Health and Company
8. Bess K. D., Fisher A. T., Sonn C. C., & Bishop B. J. (2002). Psychological sense of community: Theory, research and application. In A. T. Fisher C. C. Sonn, & B. J. Bishop (Eds.), Psychological sense of community: Research, applications, and implications (pp. 3-24). New York, NY: Kluwer Academic/Plenum Publishers
9. Binfa L., Castelo-Branco C., Blumel J. E., Cancelo M. J., Bonilla H., Munoz I., Villega Rios R. (2004). Influence of psycho-social factors on climacteric symptoms. Maturitas, 48, 425-431
10. Bosworth H. B., Bastian L. A., Rimer B. K., & Siegler I. C. (2003). Coping styles and personality domains related to menopausal stress. Women's Health Issues, 13 (1), 32-38
11. Bromberger J. T., Assman S. F., Avis N. E., Schocken M., Kravitz H. M., & Cordal A. (2003). Persistent mood symptoms in a multiethnic community cohort of pre-and peri-menopausal women. American Journal of Epidemiology, 158, 347-356. doi: 10.1093/aje/kwg155
12. Bromberger J. T., Kravitz H. M., Chang Y. F., Cyranowski J. M., Brown C., & Matthews K. (2011). Major depression during and after the menopausal transition: Study of women's health across the nation (SWAN). Psychological Medicine, 41, 1879-1888. doi: 10.1017/S003329171100016X
13. Bromberger J. T., Kravitz H. M., Matthews K., Youk A., Brown C., & Feng W. (2009). Predictors of first lifetime episodes of major depression in midlife women. Psychological Medicine, 39, 55-64
14. Bromberger J. T., Meyer P. M., Kravitz H. M., Sommer B., Cordal A., Powell L., Sutton-Tyrrell K. (2001). Psychological distress and natural menopause: A multiethnic community study. American Journal of Public Health, 91 (9), 1435-1442
15. Bromberger J. T., Schott L. L., Kravitz H. M., Sowers M. F., Avis N. E., Gold E. B., Matthews K. (2010). Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition. Archives General Psychiatry, 67 (6), 598-607
16. Brownson R. C., Eyler A. A., King A. C., Brown D. R., Shyu Y. L., & Sallis J. F. (2000). Patterns and correlates of physical activity among U.S. women 40 years and older. American Journal of Public Health, 90 (2), 264-270
17. Brugge K. L., Kripke D. F., Ancoli-Israel S., & Garfi nkel L. (1989). The association of menopausal status and age with sleep disorders. Sleep Research, 18, 208
18. Caspi A., Sugden K., Moffi tt T. E., Taylor A., Craig I. W., Harrington H., Poulton R. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301 (5631), 386-389
19. Cassano P., Soares C. N., & Cusin C. (2005). Antidepressant response and well-being in pre-, peri-, and postmenopausal women with major depressive disorder treated with fl uoxetine. Psychotherapy and Psychosomatics, 74 (6), 362-365
20. Choi H., Lee D., Lee K., Kim H., & Ham E. (2004). A structural model of menopausal depression in Korean women. Archives of Psychiatric Nursing, 18 (6), 235-242
21. Ciocca D. R., & Vargas Roig L. M. (1995). Estrogen receptors in human nontarget tissues: Biological and clinical implications. Endocrine Reviews, 16, 35-62
22. Cohen S. (1987). Social factors and depressive symptoms. Contemporary Psychology, 32 (4), 360-362. doi: 10.1037/027006
23. Cohen L. S., Soares C. N., Poitras J. R., Prouty J., Alexander A. B., & Shifren J. L. (2003). Short-term use of estradiol for depression in perimenopausal and postmenopausal women: A preliminary report. American Journal of Psychiatry, 160, 1519-1522
24. Cohen L. S., Soares C. N., Vitonis A. F., Otto M. W., & Harlow B. L. (2006). Risk for new onset of depression during the menopausal transition: The Harvard study of moods and cycles. Archives of General Psychiatry, 63 (4), 385-390. doi: 10.1001/archpsyc.63.4.385
25. Cohen L. S., & Wise P. M. (1988). Effects if estradiol on the diurnal rhythm of serotonin activity in microdissected brain areas of ovariectomized rats. Endocrinology, 122, 2619-2625
26. Collaborative Group on Hormonal Factors in Breast Cancer. (1997). Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52, 705 women with breast cancer and 108, 411 women without breast cancer. The Lancet, 350 (9084), 1047-1059
27. Cooke D. J., & Greene J. G. (1981). Types of life events in relation to symptoms at the climacterium. Journal of Psychosomatic Research, 25 (1), 5-11. http://dx.doi.org/10.1016/0022-3999%.2881%2990078-7
28. Daley A. (2008). Exercise and depression: A review of reviews. Journal of Clinical Psychology in Medical Settings, 15 (2), 140-147. http://dx.doi.org/10.1007/s10880-008-9105-z
29. Davis S. R. (2002). The effects of tibolone on mood and libido. Menopause, 9 (3), 162-170
30. Deeks A. A., & McCabe M. P. (2004). Well-being and menopause: An investigation of purpose in life, self-acceptance and social role in premenopausal, perimenopausal and postmenopausal women. Quality of Life Research, 13, 389-398
31. Dennerstein L., Dudley E., & Guthrie J. (2002). Empty nest or revolving door?. A prospective study of women's quality of life in midlife during the phase of children leaving and re-entering the home. Psychological Medicine, 32 (3), 545-550. http://dx.doi.org/10.1017/S0033291701004810
32. Dennerstein L., Lehert P., Burger H., & Dudley E. (1999). Mood and the menopausal transition. Journal of Nervous and Mental Disease, 187 (11), 685-691
33. Dennerstein L., Lehert P., Dudley E., & Guthrie J. (2001). Factors contributing to positive mood during the menopausal transition. Journal of Nervous and Mental Disease, 189 (2), 84-89
34. Dennerstein L., Smith A. M., Morse C., Burger H., Green A., Hopper J., & Ryan M. (1993). Menopausal symptoms in Australian women. The Medical Journal of Australia, 159 (4), 232-236
35. Elavsky S., & McAuley E. (2005). Physical activity, symptoms, esteem, and life satisfaction during menopause. Maturitas, 52, 374-385
36. Fink G., & Summer B. E. H. (1996). Oestrogen and mental state. Nature, 383, 306. doi: 10.1038/383306a0
37. Folkman S. (1986). Dynamics of a stressful encounter: Cognitive appraisal, coping and encounter outcomes. Journal of Personality and Social Psychology, 50 (5), 992-1003
38. Folkman S. (1997). Positive psychological states and coping with severe stress. Social Science & Medicine, 45, 1207-1221
39. Folkman S., & Lazarus R. S. (1985). If it changes it must be a process: A study of emotion and coping during three stages of a college examination. Journal of Personality and Social Psychology, 48, 150-170
40. Freeman E. W. (2010). Associations of depression with the transition to menopause. Menopause, 17 (4), 823-827
41. Freeman E. W., Sammel M. D., Gracia C. R., Kapoor S., Lin H., Liu L., & Nelson D. B. (2005). Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertility and Sterility, 83, 383-392
42. Freeman E. W., Sammel M. D., Lin H., Gracia C. R., & Kapoor S. (2008). Symptoms in the menopausal transition: Hormone and behavioural correlates. Obstetrics and Gynecology, 111 (1), 127-136. doi: 10.1097/01.AOG.0000295867.06184.b1
43. Freeman E. W., Sammel M. D., Lin H., & Nelson D. B. (2006). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry, 63 (4), 375-382. doi: 10.1001/archpsyc.63.4.375
44. Freeman E. W., Sammel M. D., & Liu L. (2004). Hormones and menopausal status as predictors of depression in women in transition to menopause. Archives of General Psychiatry, 61, 62-70
45. Freeman E. W., Sammel M. D., Rinaudo P. J., & Sheng L. (2004). Premenstrual syndrome as a predictor of menopausal symptoms. Obstetrics & Gynecology, 103 (5 pt 1), 960-966
46. Fuh J.-L., Wang S.-J., Lee S.-J., Lu S.-R., & Juang K.-D. (2006). A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas, 53 (4), 447-453. http://dx.doi.org/10.1016/j.maturitas.2005.07.009
47. Gibbs Z., Lee S., & Kulkarni J. (Unpublished Manuscript). The role of coping styles in depression during perimenopause: Use of maladaptive coping styles predicts depressive symptoms in the menopausal transition
48. Gibbs Z., Lee S., & Kulkarni J. (2013). Factors associated with depression during the perimenopausal transition. Women's Health Issues, 23 (5), e301-e307
49. Gold E. B., et al. (2000). Relation of demographic and lifestyle factors to symptoms in a multiracial/ethnic population of women 40-55 years of age. American Journal of Epidemiology 152(5), 463-473
50. Gold E. B., Block G., Crawford S., Lachance L., FitzGerald G., Miracle H., & Sherman S. (2004). Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the study of women's health across the nation. American Journal of Epidemiology, 159 (12), 1189-1199
51. Gold E. B., Colvin A., Avis N., Bromberger J., Greendale G. A., Powell L., Matthews K. (2006). Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of women's health across the nation. American Journal of Public Health, 96 (7), 1226-1235. doi: 10.2105/AJPH.2005.066936
52. Gracia C. R., Sammel M. D., Freeman E. W., Lin H., Langan E., Kapoor S., & Al E. (2005). Defi ning menopausal status: Creation of a new Definition to identify the early changes of the menopausal transition. Menopause, 12, 128-135
53. Greene J. G. (1983). Bereavement and social support at the climacteric. Maturitas, 5, 115-124
54. Greene J. G., & Cooke D. J. (1980). Life Stress and symptoms at the climacterium. British Journal of Psychiatry, 136, 486-491
55. Hardy R., & Kuh D. (2002). Change in psychological and vasomotor symptom reporting during the menopause. Social Science & Medicine, 55, 1975-1988
56. Harlow B. L., Cohen L. S., Otto M. W., Spiegelman D., & Cramer D. W. (1999). Prevalence and predictors of depressive symptoms in older perimenopausal women. Archives of General Psychiatry, 56, 418-424
57. Harlow S. D., Gass M., Hall J. E., Lobo R., Maki P. M., Rebar R., De Villiers T. J. (2012). Executive summary of the stages of reproductive aging workshop + 10: Addressing the unfi nished agenda of staging reproductive aging. Menopause: The Journal of the North American Menopause Society, 19 (4), 1159-1168. doi: 10.1097/gme.0b013e31824d8f40
58. Harlow B. L., Wise L. A., Otto M. W., Soares C. N., & Cohen L. S. (2003). Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause. Archives of General Psychiatry, 60, 29-36
59. Hecht E., & Mensh I. N. (1975). Life's ups and downs may leave you down and out. Contemporary Psychology, 20 (8), 639-640. http://dx.doi.org/10.1037/0013564
60. Holte A., & Mikkelsen A. (1991). The menopausal syndrome: A factor analytic replication. Maturitas, 13 (3), 193-203. http://dx.doi.org/10.1016/0378-5122(91)90194-U
61. Hunter M. (1992). The South-East England longitudinal study of the climacteric and postmenopause. Maturitas, 14, 117-126
62. Igarashi M., Saito H., Morioka Y., Oiji A., Nadaoka T., & Kashiwakura M. (2000). Stress vulnerability and climacteric symptoms: Life events, coping behavior, and severity of symptoms. Gynecologic & Obstetric Investigation, 49 (3), 170-178
63. Jiménez L. J., & Pérez S. G. (1999). The attitude of the woman in menopause and its influence on the climacteric. Ginecología Obstetricia De México, 67, 319-322
64. Joffe H., Fagioli L. P., Koukopoulos A., Viguera A. C., Hirschberg A., Nonacs R., Cohen L. S. (2011). Increased estradiol and improved sleep, but not hot fl ashes, predict enhanced mood during the menopausal transition. Journal of Clinical Endocrinology and Metabolism, 96 (7), 1044-1054
65. Joffe H., Hall J. E., Soares C. N., Hennen J., Reilly C. J., Carlson K., & Cohen L. S. (2002). Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause, 9, 392-398
66. Joffe H., Soares C. N., Petrillo L. F., Viguera A. C., Somley B. L., Koch J. K., & Cohen L. S. (2007). Treatment of depression and menopause-related symptoms with the serotoninnorepinephrine reuptake inhibitor duloxetine. Journal of Clinical Psychiatry, 64 (6), 473-479
67. Kafanelis B. V., Kostanski M., Komesaroff P. A., & Stojanovska L. (2009). Being in the script of menopause: Mapping the complexities of coping strategies. Qualitative Health Research, 19 (1), 30-41. doi: 10.1177/1049732308327352
68. Kornstein S. G., Schatzberg A. F., Thase M. E., Yonkers K. A., McCullough J. P., Keitner G. I., Keller M. B. (2000). Gender differences in treatment response to sertraline versus imipramine in chronic depression. American Journal of Psychiatry, 157 (9), 1445-1452
69. Kornstein S. G., Young E. A., Harvey A. T., Wisniewski S. R., Barkin J. L., Thase M. E., Rush A. J. (2010). The influence of menopausal status and postmenopausal use of hormone therapy on presentation of major depression in women. Menopause, 17 (4), 828-839. doi: 10.1097/gme.0b013e3181d770a8
70. Kraepelin E., & Diefendorf A. R. (1907). Clinical psychiatry: A textbook for students and physicians, abstracted and adapted from the 7th German edition of Kraepelin's Lehrbuch der Psychiatrie (new ed., rev, and augmented). New York, NY: Macmillan
71. Kronenberg F. (1990). Hot fl ashes: Epidemiology and physiology. Annals of the New York Academy of Science, 592, 52-86
72. Kulkarni J., Fitzgerald P., & Seeman M. V. (2012). The clinical needs of women with schizophrenia. In D. Castle D. Copolov T. Wykes, & K. Mueser (Eds.), Pharmacological and psychosocial treatments in schizophrenia (pp. 183-201). London: Informa Healthcare
73. Lazarus R. S. (1991). Emotion and adaptation. In L. A. Pervin (Ed.), Handbook of personality: Theory and research (pp. 609-637). New York, NY: Guilford
74. Lee Y., & Kim H. (2008). Relationships between menopausal symptoms, depression, and exercise in middle-aged women: A cross-sectional survey. International Journal of Nursing Studies, 45, 1816-1822
75. Lokuge S., Frey B. N., Foster J. A., Soares C. N., & Steiner M. (2011). Depression in women: Windows of vulnerability and new insights into the link between estrogen and serotonin. The Journal of Clinical Psychiatry, 72 (11), e1563-e1569. doi: 10.4088/JCP.11com07089
76. Mahe V., & Dumain A. (2001). Oestrogen withdrawal associated psychoses. Acta Psychiatrica Scandinavica, 104, 323-331
77. Matsuda T., Nakano Y., Kanda T., Iwata H., & Baba A. (1991). Gonadal hormones affect the hypothermia induced by serotonin1A (5-HT1A) receptor activation. Life Sciences, 48 (17), 1627-1632. http://dx.doi.org/10.1016/0024-3205(91)90122-R
78. Miech R. A., & Shanahan M. J. (2000). Socioeconomic status and depression over the life course. Journal of Health and Social Behavior, 41 (2), 162-176. http://dx.doi.org/10.2307/2676303
79. Mirzaiinjmabadi K., Anderson D., & Barnes M. (2006). The relationship between exercise, Body Mass Index and menopausal symptoms in midlife Australian women. International Journal of Nursing Practice, 12 (1), 28-34
80. Moline M. L., Broch L., Zak R., & Gross V. (2003). Sleep in women across the life cycle from adulthood through menopause. Sleep Medicine Reviews, 7 (2), 155-177. http://dx.doi. org/10.1053/smrv.2001.0228
81. Morrison J. H., Brinton R. D., Schmidt P. J., & Gore A. C. (2006). Estrogen, menopause, and the aging brain: How basic neuroscience can inform hormone therapy in women. Journal of Neuroscience, 26 (41), 10332-10348. doi: 10.1523/jneurosci.3369-06.2006
82. Morse C. A., Dudley E., Guthrie J., & Dennerstein L. (1998). Relationships between premenstrual complaints and perimenopausal experiences. Journal of Psychosomatic Obstetrics & Gynecology, 19 (4), 182-191
83. Murrell S. A., Himmelfarb S., & Wright K. (1983). Prevalence of depression and its correlates in older adults. American Journal of Epidemiology, 117 (2), 173-185
84. Ozturk O., Eraslan D., Mete H. E., & Ozsener S. (2006). The risk factors and symptomatology of perimenopausal depression. Maturitas, 55 (2), 180-186. http://dx.doi.org/10.1016/j. maturitas.2006.02.001
85. Parry B. L. (2008). Perimenopausal depression. American Journal of Psychiatry, 165 (1), 23-27. doi: 10.1176/appi.ajp.2007.07071152
86. Parry B. L. (2010). Optimal management of perimenopausal depression. International Journal of Women's Health, 2, 143-151
87. Payne J. L. (2003). The role of estrogen in mood disorders in women. International Review of Psychiatry, 15, 280-290. doi: 10.1080/0954026031000136893
88. Payne J. L., Roy P. S., Murphy-Eberenz K., Weismann M. M., Swartz K. L., McInnis M. G., Potash J. B. (2007). Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. Journal of Affective Disorders, 99 (1-3), 221-229. Retrieved from http://dx.doi.org/10.1016/j.jad.2006.08.013
89. Payne J. L., Teitelbaum P. J., & Joffe H. (2009). A reproductive subtype of depression: Conceptualizing models and moving toward etiology. Harvard Review of Psychiatry, 17 (2), 72-86. doi: 10.1080/10673220902899706
90. Raup J. L., & Myers J. E. (1989). The empty nest syndrome: Myth or reality?. Journal of Counseling & Development, 68 (2), 180-183
91. Reed M. J., & Kloosterboer H. J. (2004). Tibolone: A selective tissue estrogenic activity regulator (STEAR). Maturitas, 48 (Supplement 1), 4-6
92. Reed S. D., Ludman E. J., Newton K. M., Grothaus L. C., LaCroix A. Z., Nekhlyudov L., Bush T. (2009). Depressive symptoms and menopausal burden in the midlife. Maturitas, 62 (3), 306-310
93. Richards M., Rubinow D. R., Daly R. C., & Schmidt P. J. (2006). Premenstrual symptoms and perimenopausal depression. American Journal of Psychiatry, 163 (1), 133-137. doi: 10.1176/appi.ajp.163.1.133
94. Riecher-Rössler A. (2003). Oestrogens and schizophrenia. Current Opinion in Psychiatry, 16 (2), 187-192
95. Riecher-Rössler A. (2005). Estrogens and schizophrenia. In N. Bergemann & A. Riecher-Rössler (Eds.), Estrogen effects in psychiatric disorders (pp. 31-52). Wien: Springer
96. Risch N., Herrell R., Lehner T., Liang K. Y., Eaves L., Hoh J., Merikangas K. R. (2009). Interaction between the serotonin transporter gene (5-httlpr), stressful life events, and risk of depression: A meta-analysis. Journal of the American Medical Association, 301 (23), 2462-2471. doi: 10.1001/jama.2009.878
97. Rostrosky S. S., & Travis C. B. (1996). Menopause research and the dominance of the biomedical model 1984-1994. Psychology of Women Quarterly, 20, 285-312
98. Rubinow D. R., Roca C. A., & Schmidt P. J. (2007). Estrogens and depression in women. In R. A. Lobo (Ed.), Treatment of the postmenopausal woman: Basic and clinical aspects. New York, NY: Elsevier
99. Rubinow D. R., Schmidt P. J., & Roca C. A. (1998). Estrogen-serotonin interactions: Implications for affective regulation. Biological Psychiatry, 44 (9), 839-850. http://dx.doi.org/10.1016/S0006-3223(98)00162-0
100. Schiff I., Regestein Q., Tulchinsky D., & Ryan K. J. (1979). Effects of estrogens on sleep and psychological state of hypogonadal women. Journal of the American Medical Association, 242 (22), 2405-2407
101. Schmidt P. J., Haq N., & Rubinow D. R. (2004). A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. American Journal of Psychiatry, 161 (12), 2238-2244. doi: 10.1176/appi.ajp.161.12.2238
102. Schmidt P. J., Murphy J., Haq N., Rubinow D. R., & Danaceau M. (2004). Stressful life events, personal losses, and perimenopause-related depression. Archives of Women's Mental Health, 7 (1), 19-26
103. Schmidt P. J., Nieman L., Danaceau M. A., Tobin M. B., Roca C. A., Murphy J. H., & Rubinow D. R. (2000). Estrogen replacement in perimenopause-related depression: A preliminary report. American Journal of Obstetrics and Gynecology, 183 (2), 414-420. Retrieved from http://dx.doi.org/10.1067/mob.2000.106004
104. Schmidt P. J., Roca C. A., Bloch M., & Rubinow D. R. (1997). The perimenopause and affective disorders. Seminars in Reproductive Endocrinology, 15 (1), 91-100. doi: 10.1055/s-2008-1067971
105. Schmidt P. J., & Rubinow D. R. (1991). Menopause-related affective disorders: A justifi cation for further study. American Journal of Psychiatry, 148 (7), 844-852
106. Seritan A. L., Iosif A. M., Park J. H., DeatherageHand D., Sweet R. L., & Gold E. B. (2010). Self-reported anxiety, depressive, and vasomotor symptoms: A study of perimenopausal women presenting to a specialized midlife assessment center. Menopause, 17 (2), 410-415
107. Soares C. N., Almeida O. P., Joffe H., & Cohen L. S. (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebocontrolled trial. Archives of General Psychiatry, 58 (6), 529-534
108. Soares C. N., Arsenio H., Joffe H., Bankier B., Cassano P., Petrillo L. F., & Cohen L. S. (2006). Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic periand postmenopausal women: Impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause, 13 (5), 780-786
109. Soares C. N., Poitras J. R., Prouty J., Alexander A. B., Shifren J. L., & Cohen L. S. (2003). Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. Journal of Clinical Psychiatry, 64 (4), 473-479
110. Soules M. R., Sherman S., Parrott E., Rebar R., Santoro N., Utian W., & Woods N. (2001). Executive summary: Stages of reproductive aging workshop (STRAW). Climacteric, 4 (4), 267-272
111. Sternfeld B., Quesenberry C., & Husson G. (1999). Habitual physical activity and menopausal symptoms. Journal of Women's Health, 8, 115-123
112. Stewart D. E., & Boydell K. M. (1993). Psychologic distress during menopause: Associations across the reproductive life cycle. International Journal of Psychiatry in Medicine, 23, 157-162
113. Stotland N. L. (2002). Menopause: Social expectations, women's realities. Archives of Women's Mental Health, 5 (1), 5-8. doi: 10.1007/s007370200016
114. Sumner B. E. H. (1995). Estrogen increases the density of 5-hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat. The Journal of Steroid Biochemistry and Molecular Biology, 54 (1-2), 15. http://dx.doi.org/10.1016/0960-0760(95)00075-B
115. Swegle J. M., & Kelly M. W. (2004). Tibolone: A unique version of hormone replacement therapy. Annals of Pharmacotherapy, 38 (5), 874-881. doi: 10.1345/aph.1D462
116. Tam L. W., Stucky V., Hanson R. E., & Parry B. L. (1999). Prevalence of depression in menopause: A pilot study. Archives of Women's Mental Health, 2 (4), 175-181
117. Thurston R., Joffe H., Soares C. N., & Harlow B. L. (2006). Physical activity and risk of vasomotor symptoms in women with and without a history of depression: Results from the Harvard study of moods and cycles. Menopause, 13, 553-560
118. Timur S., & Sahin N. H. (2010). The prevalence of depression symptoms and infl uencing factors among perimenopausal and postmenopausal women. Menopause, 17 (3), 545-551
119. Veeninga A. T., & Kraaimaat F. W. (1989). Life stress and symptoms in menopause clinic patients and non-patients. Journal of Psychosomatic Obstetrics & Gynecology, 10 (3), 269-277. doi: 10.3109/01674828909016700
120. Whiteman M. K., Staropoli C. A., Benedict J. C., Borgeest C., & Flaws J. A. (2003). Risk factors for hot fl ashes in midlife women. Journal of Women's Health, 12, 459-472
121. Wilbur J., Dan A., Hedricks C., & Holm K. (1990). The relationship among menopausal status, menopausal symptoms, and physical activity in midlife women. Family and Community Health, 13, 67-78
122. Woods N. F., & Mitchell E. S. (1996). Patterns of depressed mood in midlife women: Observations from the Seattle midlife women's health study. Research in Nursing and Health, 19, 111-123
123. Woods N. F., & Mitchell E. S. (1997). Pathways to depressed mood for midlife women: Observations from the Seattle midlife women's health study. Research in Nursing and Health, 20, 119-129
124. Woods N. F., Smith-DiJulio K., Percival D. B., Tao E. Y., Mariella A., & Mitchell E. S. (2008). Depressed mood during the menopausal transition and early postmenopause: Observations from the Seattle midlife women's health study. Menopause: The Journal of The North American Menopause Society, 15 (3), 223-232
125. Worsley R., Davis S. R., Gavrilidis E., Gibbs Z., Lee S., Burger H., & Kulkarni J. (2012). Hormonal therapies for new onset and relapsed depression during perimenopause. Maturitas, 73 (2), 127-133. doi: 10.1016/j.maturitas.2012.06.011
126. Writing Group for the Women's Health Initiative Investigators. (2002). Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. Journal of the American Medical Association, 288 (3), 321-333. doi: 10.1001/jama.288.3.321
127. Zweifel J. E., & O'Brien W. H. (1997). A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology, 22 (3), 189-212